You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
和黃醫藥(00013.HK):將繼續評估保持在美國上市所有選項
和黃醫藥(00013.HK)(HCM.US)表示,美國證交會(SEC)將和黃醫藥列入其根據該法案認定的發行人最終清單上。繼公司於2022年3月3日向美國證交會呈交20-F表格內的年度報告後,公司於2022年3月8日被暫定爲委員會認定的發行人。美國證交會之前估計根據該法案有273名註冊人可能於2020年的審查中被視爲委員會認定的發行人。公司預計,當其他在香港和中國其他地區有業務的類似美國上市公司向美國證交會提交年度報告後,該等公司將會被列入在清單內。 公司正繼續留意市場發展及評估所有的戰略選項,並在適當諮詢和指導下,公司謹此指出這一更新對業務營運並無影響。 和黃醫藥瞭解該法案的初衷是確保適當的透明度和披露,讓投資者能夠作出知情的投資決定。公司對此全力支持且亦是公司自2006年在倫敦首次上市以來的一貫承諾。公司將一如既往繼續遵守公司上市所在所有司法管轄區的相關法律和法規。此外,公司正與中國證監會保持溝通,以瞭解他們與美國當局就設於中國的公司如何能滿足該法案的要求所進行的討論是否有進一步更新。公司將繼續評估保持在美國上市的所有選項,包括在公司的國際業務對集團的貢獻超過中國業務時,評估在中國境外委聘審計師的好處。 公司的美國預託證券將繼續在納斯達克全球精選市場上交易,每份美國預託證券代表五股普通股。其普通股則可於AIM市場上交易。此外,於2021年6月30日,公司於港交所(00388.HK)主板完成普通股主要上市,股份代號「13」。於香港交易所及AIM市場上市的股份可悉數與公司的美國預託證券所代表的股份代替或互換。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account